Filing Details

Accession Number:
0001144204-13-057263
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-28 21:30:53
Reporting Period:
2013-10-24
Filing Date:
2013-10-28
Accepted Time:
2013-10-28 21:30:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100397 Advaxis Inc. ADXS Pharmaceutical Preparations (2834) 841521955
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376847 Daniel O'connor 305 College Road East
Princeton NJ 08540
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-24 13,500 $4.00 61,256 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2013-10-24 6,750 $0.00 6,750 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,750 2013-10-22 2018-10-22 No 4 P Direct
Footnotes
  1. Voluntarily purchased with cash portion of transaction bonus plus additional personal funds.